GPCR Structure Therapeutics Inc. American
Company Analysis
Latest News
🟢 Structure Therapeutics is trading 6% up today amid supportive biotech-sector sentiment
Structure Therapeutics is trading at $23.33, up 6.00%, amid supportive biotech-sector sentiment. - The XBI sector ETF is up 2.10% during the regular session. -...
🟢 Structure Therapeutics is trading 5% up today amid a supportive biotech backdrop
Structure Therapeutics is trading 5.03% higher at $22.14 on October 19, 2026; the move appears consistent with a supportive market backdrop, with no verified...
🟢 Structure Therapeutics is trading 8.9% up in after-hours trading
Structure Therapeutics is trading at $22.95, up 8.87% from the October 16 regular-session close of $21.08; no verified company-specific announcement explaining...
🔴 Structure Therapeutics is trading 5% down today as biotech and broader markets sold off
Structure Therapeutics is trading 5.32% down at $21.01 on October 16, 2026, amid biotech and broader market weakness; no fresh company-specific catalyst was...
🔴 Structure Therapeutics is trading 4.22% down amid biotech-sector weakness
Structure Therapeutics is trading 4.22% down at $22.90; no company-specific announcement explaining the October 13 move surfaced, and biotech-sector pressure...
🟢 Structure Therapeutics is trading 4.3% up in after-hours trading; no clear company-specific catalyst identified
Structure Therapeutics is trading 4.27% higher at $24.93 after hours, with no clear catalyst identified. - The regular-session close fell 6.38% to $23.91 on...
🔴 Structure Therapeutics is trading 4.07% down as session catalyst remains unclear
Structure Therapeutics is trading 4.07% lower at $24.50, with no clearly linked catalyst identified for the session. - The broad market is nearly flat, and...
🔴 Structure Therapeutics is trading 6.51% down in pre-market with no clear catalyst identified
Structure Therapeutics is trading at $24.00, down 6.51% in pre-market, with no clear catalyst identified. - No fresh company-specific announcement was...
🔴 Structure Therapeutics is trading 4.33% down today as global risk-off pressure weighs on biotech shares
Structure Therapeutics is trading 4.33% down at $25.52 on October 8, 2026, amid broad risk-off pressure. - No fresh company-specific announcement explaining...
🔴 Structure Therapeutics is trading 5% down in pre-market amid possible broader market pressure
Structure Therapeutics is trading at $25.22, down 5.47%, with broader risk-off sentiment a possible backdrop. - No fresh company-specific announcement or...
🔴 Structure Therapeutics is trading 4.6% down in pre-market with no clear catalyst identified
Structure Therapeutics is trading 4.6% down at $26.32 in pre-market on October 6, 2026, with no fresh company-specific announcement identified to explain the...
🔴 Structure Therapeutics is trading 4.37% down with no clear company-specific catalyst identified
Structure Therapeutics is trading 4.37% down at $26.46; no clear company-specific catalyst was identified for the October 5, 2026 decline. - The latest listed...
🔴 Structure Therapeutics is trading 4.14% down — no clear catalyst identified
Structure Therapeutics is trading at $27.78, down 4.14%, with no clear company-specific catalyst identified for the October 2, 2026 decline. - Reports pointed...
🔴 Structure Therapeutics is trading 4.06% down amid broad market pressure
Structure Therapeutics is trading 4.06% down at $30.00 on October 1, 2026, amid broad market pressure; no clear company-specific catalyst was identified. -...
🔴 Structure Therapeutics is trading 5% down
Structure Therapeutics is trading 4.86% lower at $31.10 on September 30, 2026, with no clear catalyst identified. - This marks a second consecutive session of...
🔴 Structure Therapeutics is trading 4.06% down
Structure Therapeutics is trading 4.06% down at $33.64, with no verified company-specific announcement explaining the September 29 decline. - A market roundup...
🟢 Structure Therapeutics is trading at 4.3% up in pre-market as biotech sentiment strengthens
Structure Therapeutics is trading up 4.3% now at $37.50, with the move appearing mainly linked to stronger biotechnology sentiment. - Shares rebounded from...
🔴 Structure Therapeutics is trading 4.1% down today amid weaker broad-market sentiment
Structure Therapeutics is trading 4.1% lower at $35.38, with the decline appearing mainly linked to weaker broad-market sentiment. - The Nasdaq is down 1.04%,...
🔴 Structure Therapeutics is trading 5% down in pre-market as catalyst remains unclear
Structure Therapeutics is trading 5.17% lower at $35.00 in pre-market, with the catalyst unclear. - No clear company-specific announcement, earnings release,...
🟢 Structure Therapeutics is trading 4.5% up today amid strong September 21, 2026 equity rally
Structure Therapeutics is trading 4.5% up at $36.57, moving higher alongside a strong September 21, 2026 equity rally. - The S&P 500 was up 0.99%, while the...